Pac1r The pacap peptide, scientifically known as Pituitary adenylate cyclase-activating polypeptide, is a fascinating and multifaceted neuropeptide that plays a crucial role in a wide array of physiological and pathophysiological processes. First isolated from ovine hypothalamic extracts, this polypeptide has garnered significant attention from researchers due to its potent ability to stimulate adenylate cyclase activity in cells, leading to increased cyclic AMP (cAMP) levels2025年11月25日—Adenylate cyclase-activatingpolypeptide1 gene methylation predicts prognosis and the immune microenvironment of bladder cancer.PACAP-38 in .... In humans, the gene responsible for producing pacap is ADCYAP1, highlighting its fundamental genetic basis.
PACAP is a highly conserved neuropeptide, with its amino acid sequence being identical across all mammals, underscoring its evolutionary importance. It exists primarily in two forms: a 27-amino acid and a 38-amino acid variant, with PACAP 1-38 being particularly well-studied. This PACAP 1-38 is a potent endogenous neuropeptide, exhibiting considerable homology with Vasoactive Intestinal Peptide (VIP), but with significantly greater potency. Another related molecule, the PACAP-Related Peptide (PRP), human, is also a significant player, being an endogenous 29-amino acid peptide that belongs to the secretin/glucagon superfamily.PACAP-related peptide (PRP) is an endogenous 29-amino acid peptide that belongs to the secretin/glucagon superfamily of peptides, which includes secretin (Item ...
The distribution of PACAP is extensive, with a notable presence in the brain, including the hypothalamus, as well as in various peripheral tissues.2JOD: Pac1-Rshort N-terminal EC domain Pacap(6-38) ... Evidence suggests that PACAP is expressed within the rat and human placenta, indicating its involvement in reproductive functionsPACAP 1-38(CAS Number: 137061-48-4) is a mammalian polypeptide which stimulates adenylate cyclase and increases cAMP levels in cells.. Furthermore, PACAP is recognized as a pathogen-inducible resident antimicrobial neuropeptide, suggesting a role in immune responsesVIP and PACAP receptors | Introduction. Its intricate involvement in neuroendocrine and behavioral stress regulation is also a subject of ongoing research.
The mechanism of action for pacap peptide primarily involves binding to its specific receptors, such as the PAC1 receptor (also known as Pac1r). These receptors are Gs/Gq-coupled, allowing PACAP to regulate neuronal physiology and transcription. The PAC1 receptor is known to be involved in various cellular processes, and studies have explored the structural dynamics of pacap when bound to these receptors, with the PACAP peptide adopting a helical conformation when bound to the hPAC1-R(S) variantPituitary adenylate cyclase-activating polypeptidealso known as PACAP is a protein that in humans is encoded by the ADCYAP1 gene..
Beyond its immediate cellular effects, pacap has been implicated in a broad spectrum of biological phenomena. Research has shown that PACAP increases the survival of cultured dorsal root ganglion (DRG) neurons, with its effects being comparable to those of nerve growth factor (NGF). This neurotrophic activity highlights its critical role in neuronal development and maintenance.PACAP 1-38is a potent endogenous neuropeptide (IC 50 = 2 nM) showing considerable homology with vasoactive intestinal peptide (VIP) but with a greater potency. Studies have also indicated that PACAP is an early inducer of cAMP levels in the embryo and may act in the neural tube during patterning to control cell proliferation and gene expression, suggesting its importance in early embryonic development.
The significance of PACAP extends to various physiological processes, including the regulation of mammalian reproductive function. Its presence in the brain and its ability to influence neuroendocrine pathways point to its role in mediating complex biological responses. Moreover, PACAP is involved in immune responses, and research is exploring its potential role in conditions such as SIDS (Sudden Infant Death Syndrome), with PACAP deficiency potentially offering a promising avenue for investigation.
The therapeutic potential of PACAP and its related peptides is also being explored. Research into designing drugs for the PACAP subfamily of receptors is an active area of investigationPACAP (1-38), a novel neuropeptideisolated from the bovine hypothalamus is more active than vasoactive intestinal peptide (VIP) in stimulating adenylate .... Given its diverse roles, understanding the precise functions and interactions of the pacap peptide is crucial for advancing our knowledge of cellular signaling, neurobiology, and the development of novel therapeutic strategies for a range of conditions, including potentially PACAP in migraine treatment. The PACAP gene (ADCYAP1) and its role in methylation predicting prognosis and the immune microenvironment of bladder cancer in 2025 further underscores the expanding scope of PACAP research.
In summary, the pacap peptide is a vital neuropeptide with profound implications for cellular communication, neuronal function, embryonic development, and immune regulation. From its initial discovery as a potent adenylate cyclase activator to its emerging roles in complex physiological and pathophysiological processes, PACAP continues to be a subject of intense scientific inquiry, promising further insights into human health and disease. The study of PACAP and its related molecules, including PACAP-38, offers a rich landscape for scientific discovery and potential therapeutic interventions.
Join the newsletter to receive news, updates, new products and freebies in your inbox.